|
MNPR Monopar Therapeutics Inc 1645469 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-3,893,050.00 |
| Balance Sheet |
|
Current Assets
|
$137,743,843.00 |
|
Assets
|
$137,983,725.00 |
|
Current Liabilities
|
$2,457,748.00 |
|
Liabilities
|
$2,589,313.00 |
|
Equity
|
$135,394,412.00 |
|
Shares Out
|
6699062.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-3,473,906.00 |
|
Investing Cash Flow
|
$-5,583,552.00 |
| Market Analysis |
Market Cap
|
$768,114,448.92 |
|
Price
|
$107.46 |
|
BVPS
|
20.21 |
|
PB
|
5.67 |
|
EPS
|
-0.46 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:30 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:26 |
|
| Apr |
May |
Jun |
| 2026-03-27 |
-0.61 |
|
|
2026-05-14 |
-0.46 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-13 |
-0.48 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view MNPR documents filed with the SEC.
MNPR Filings
Clear
